Zobrazeno 1 - 10
of 13
pro vyhledávání: '"James, Leverenz"'
Autor:
Sara Taylor, Seerat Sachdeva, Sandra Darling, Kayela Arrotta, Lisa Gallagher, Alexis Supan, Gabrielle Shipta, Jim Perko, Judi Bar, Joe James, Iris Petschek, Anthony Lioi, Suman Kundu, Lisa Ellison, Lynn M. Bekris, Belinda Willard, Naseer Sangwan, Ignacio Mata, Hubert Fernandez, Irene Katzan, Devon Conway, Jagan Pillai, James Leverenz, Robyn M. Busch, Darlene Floden, Robert Saper, John Barnard, Andre Machado, Imad Najm, Vineet Punia
Publikováno v:
Neurological Research and Practice, Vol 6, Iss 1, Pp 1-9 (2024)
Abstract Introduction Given the prevalence and staggering cost of neurological disorders, there is dire need for effective early detection and intervention tools. Emerging evidence suggests that multidisciplinary lifestyle interventions (MLI) may mit
Externí odkaz:
https://doaj.org/article/d098fa6f801b42dfb525f8e5974a3bf3
Autor:
Kathryn Martinez, ALAN J LERNER, Paul J Ford, Lauren R Sankary, Valerie Rico, Megan Zelinsky, Helen S Webster, Babak Tousi, James Leverenz
Publikováno v:
BMJ Open, Vol 14, Iss 8 (2024)
Introduction Informed decisions to enrol in the clinical investigations of Alzheimer’s disease and related dementias (ADRD) require careful consideration of complex risks and uncertain benefits. Decisions regarding whether to receive information ab
Externí odkaz:
https://doaj.org/article/4391d4a0c0f14482970f1fe636649a21
Autor:
Jennifer G. Goldman, Leah K. Forsberg, Bradley F. Boeve, Melissa J. Armstrong, David J. Irwin, Tanis J. Ferman, Doug Galasko, James E. Galvin, Daniel Kaufer, James Leverenz, Carol F. Lippa, Karen Marder, Victor Abler, Kevin Biglan, Michael Irizarry, Bill Keller, Leanne Munsie, Masaki Nakagawa, Angela Taylor, Todd Graham
Publikováno v:
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-11 (2020)
Abstract Lewy body dementia (LBD), including dementia with Lewy bodies and Parkinson’s disease dementia, affects over a million people in the USA and has a substantial impact on patients, caregivers, and society. Symptomatic treatments for LBD, whi
Externí odkaz:
https://doaj.org/article/124897cd94684017aeb29777e23d2e1b
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease
Autor:
Daniel Weintraub, Chelsea Caspell‐Garcia, Tanya Simuni, Hyunkeun R. Cho, Christopher S. Coffey, Dag Aarsland, Roy N. Alcalay, Matthew J. Barrett, Lana M. Chahine, Jamie Eberling, Alberto J. Espay, Jamie Hamilton, Keith A. Hawkins, James Leverenz, Irene Litvan, Irene Richard, Liana S. Rosenthal, Andrew Siderowf, Michele York, Parkinson’s Progression Markers Initiative
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 7, Iss 4, Pp 449-461 (2020)
Abstract Objective To determine the evolution of numerous neuropsychiatric symptoms and cognitive abilities in Parkinson disease from disease onset. Methods Prospectively collected, longitudinal (untreated, disease onset to year 5), observational dat
Externí odkaz:
https://doaj.org/article/1733fdc8d0954e2d9d18b60b48a839a0
Autor:
Bethany Peterson, Melissa Armstrong, Douglas Galasko, James E. Galvin, Jennifer Goldman, David Irwin, Henry Paulson, Daniel Kaufer, James Leverenz, Angela Lunde, Ian G. McKeith, Andrew Siderowf, Angela Taylor, Katherine Amodeo, Matt Barrett, Kimiko Domoto-Reilly, John Duda, Stephen Gomperts, Neill Graff-Radford, Samantha Holden, Lawrence Honig, Daniel Huddleston, Carol Lippa, Irene Litvan, Carol Manning, Karen Marder, Charbel Moussa, Chiadi Onyike, Fernando Pagan, Alexander Pantelyat, Victoria Pelak, Kathleen Poston, Joseph Quinn, Irene Richard, Liana S. Rosenthal, Marwan Sabbagh, Douglas Scharre, Sharon Sha, Holly Shill, Yasar Torres-Yaghi, Tina Christie, Todd Graham, Ian Richards, Mike Koehler, Brad Boeve
Publikováno v:
Alzheimer’s Research & Therapy, Vol 11, Iss 1, Pp 1-4 (2019)
Abstract The first Lewy Body Dementia Association (LBDA) Research Centers of Excellence (RCOE) Investigator’s meeting was held on December 14, 2017, in New Orleans. The program was established to increase patient access to clinical experts on Lewy
Externí odkaz:
https://doaj.org/article/78d82e5caeeb47d5b89d124143fa80b8
Publikováno v:
Sunday, April 23.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd782482fd5077346c287abe09eb2970
https://doi.org/10.1212/wnl.0000000000201991
https://doi.org/10.1212/wnl.0000000000201991
Publikováno v:
Wednesday, April 26.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::017feecc3af8132493284dbee90da43d
https://doi.org/10.1212/wnl.0000000000202674
https://doi.org/10.1212/wnl.0000000000202674
Autor:
Sayyidah Afifa, Birgit Högl, Nicola Pavese, David Standaert, Lana Chahine, Dominic Rowe, Klaus Seppi, James Leverenz, Kenneth Marek, Keith Hawkins, Todd Sherer, Amy Amara, David Brooks
Publikováno v:
Movement Disorders. 30:1371-1381
Parkinson's disease (PD) is a progressive neurodegenerative condition associated with a broad scope of motor and nonmotor symptoms (NMS). Excessive daytime sleepiness (EDS) is one of the most common and debilitating manifestations of NMS in PD. The r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d4a1cbfba8987c1e21bc9c425aa81cf
https://doi.org/10.1002/mds.26248
https://doi.org/10.1002/mds.26248
Autor:
Debby Tsuang, M. Ilyas Kamboh, Steven DeKosky, Joseph Buxbaum, Roger Albin, M Michael Barmada, James Leverenz, Kathryn Lunetta, Andrew Saykin, Celeste Karch, Gregory Jicha, Alison Goate, Lubov Ezerskiy, John Hardy, F. Yesim Demirci, Wayne Poon, Chiao-Feng Lin
Publikováno v:
PLoS ONE
PloS one, vol 11, iss 2
PLoS ONE, Vol 11, Iss 2, p e0148717 (2016)
PloS one, vol 11, iss 2
PLoS ONE, Vol 11, Iss 2, p e0148717 (2016)
Late onset Alzheimer's disease (LOAD) is a genetically complex and clinically heterogeneous disease. Recent large-scale genome wide association studies (GWAS) have identified more than twenty loci that modify risk for AD. Despite the identification o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e8558b443d1e7e926ef62f742fea405
https://pubmed.ncbi.nlm.nih.gov/26919393
https://pubmed.ncbi.nlm.nih.gov/26919393
Autor:
Christine R, Swanson, Katherine, Li, Travis L, Unger, Michael D, Gallagher, Vivianna M, Van Deerlin, Pinky, Agarwal, James, Leverenz, John, Roberts, Ali, Samii, Rachel Goldmann, Gross, Howard, Hurtig, Jacqueline, Rick, Daniel, Weintraub, John Q, Trojanowski, Cyrus, Zabetian, Alice S, Chen-Plotkin
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 30(6)
The discovery of novel plasma-based biomarkers could lead to new approaches in the treatment of Parkinson's disease (PD). Here, we explore the role of plasma apolipoprotein A1 (ApoA1) as a risk marker for PD and evaluate the influence of APOA1 promot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::96b695c221cf5e85aef78a7b8ea91c20
https://pubmed.ncbi.nlm.nih.gov/25227208
https://pubmed.ncbi.nlm.nih.gov/25227208